We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oncimmune Holdings Plc | LSE:ONC | London | Ordinary Share | GB00BYQ94H38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 24.80 | 22.40 | 25.80 | 59,883 | 08:36:09 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Medical Laboratories | 1.47M | -6.15M | -0.0830 | -2.99 | 18.39M |
From Apr 2019 to Apr 2024
TIDMONC
RNS Number : 6778O
Oncimmune Holdings PLC
08 November 2016
8 November 2016
Oncimmune Holdings plc
("Oncimmune" or the "Company")
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PDMR AND PERSONS CLOSELY ASSOCIATED WITH THEM
Oncimmune Holdings plc (AIM: ONC.L), a leading early cancer detection company developing and commercialising its proprietary EarlyCDT(R) platform technology, today announces that on 8 November 2016, options over ordinary shares of the Company were awarded to certain Directors and certain PDMRs under the Company's 2016 Share Option Plan (an amalgamation of the Company's 2005 and 2007 Share Option Plans) as follows.
Hot Features
Premium
Name Position Number Option Percentage
of share exercise of issued
options price share capital
awarded per share (%)
(pence)
--------------------------- ------------------- ---------- ----------- ---------------
Non-executive
Meinhard Schmidt Chairman 120,370 108 0.236
--------------------------- ------------------- ---------- ----------- ---------------
Chief Executive
Geoffrey Hamilton-Fairley Officer 528,273 1 1.035
--------------------------- ------------------- ---------- ----------- ---------------
119,875 108 0.235
----------------------------------------------- ---------- ----------- ---------------
Chief Financial
Andrew Millet Officer 92,593 108 0.181
--------------------------- ------------------- ---------- ----------- ---------------
Chief Operational
Andrea Murray Scientist 41,667 108 0.082
--------------------------- ------------------- ---------- ----------- ---------------
Chief Commercial
Maarten Brusse Officer 74,074 108 0.145
--------------------------- ------------------- ---------- ----------- ---------------
The options are subject to the rules of the 2016 Share Option Plan and vest in five equal annual parts, the first fifth vesting on 7 November 2017 and each year thereafter for a further four years, subject to continued employment. Unless otherwise indicated in the table above, the options are exercisable at 108 pence, being the mid-market closing price of the Company's ordinary shares on 7 November 2016
For further information:
Oncimmune Holdings plc
Geoffrey Hamilton-Fairley, Chief Executive Officer
contact@oncimmune.co.uk
Zeus Capital Limited (Nominated Adviser and Broker)
Phil Walker, Giles Balleny, Dominic Wilson
+44 (0) 203 829 5000
Media enquiries:
Consilium Strategic Communications
Chris Gardner, Mary-Jane Elliott, Matthew Neal, Lindsey Neville
oncimmune@consilium-comms.com
+44 (0) 20 3709 5708
1 Details of the person discharging managerial responsibilities/person closely associated
---- ----------------------------------------------------------------------------------------------------------------
a) Name Meinhard Schmidt
---- ------------------------------------------------------- -------------------------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------------------------------------------------
Non-Executive Chairman, Director
a) Position/status
---- ------------------------------------------------------- -------------------------------------------------------
b) Initial notification/Amendment Initial Notification
---- ------------------------------------------------------- -------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Oncimmune Holdings plc
---- ------------------------------------------------------- -------------------------------------------------------
b) LEI N/A
---- ------------------------------------------------------- -------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of options over 1p ordinary shares - 2016 Share Option
instrument Plan
Identification code
ISIN GB00BYQ94H38
---- ------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Grant of options over ordinary shares
---- ------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- ----------
N/A 120,370
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
d) Aggregated information Price(s) Volume(s)
---------- ----------
N/A 120,370
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 8 November 2016
---- ------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction N/A
---- ------------------------------------------------------- -------------------------------------------------------
1 Details of the person discharging managerial responsibilities/person closely associated
---- ----------------------------------------------------------------------------------------------------------------
a) Name Geoffrey Hamilton-Fairley
---- ------------------------------------------------------- -------------------------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------------------------------------------------
Chief Executive Officer
a) Position/status
---- ------------------------------------------------------- -------------------------------------------------------
b) Initial notification/Amendment Initial Notification
---- ------------------------------------------------------- -------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Oncimmune Holdings Plc
---- ------------------------------------------------------- -------------------------------------------------------
b) LEI N/A
---- ------------------------------------------------------- -------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of options over 1p ordinary shares - 2016 Share Option
instrument Plan
Identification code ISIN GB00BYQ94H38
---- ------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Grant of options over ordinary shares
---- ------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- ----------
N/A 528,273
---------- ----------
N/A 119.875
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
d) Aggregated information Price(s) Volume(s)
---------- ----------
N/A 648,148
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 8 November 2016
---- ------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction N/A
---- ------------------------------------------------------- -------------------------------------------------------
1 Details of the person discharging managerial responsibilities/person closely associated
---- ----------------------------------------------------------------------------------------------------------------
a) Name Andrew Millet
---- ------------------------------------------------------- -------------------------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------------------------------------------------
Chief Financial Officer
a) Position/status
---- ------------------------------------------------------- -------------------------------------------------------
b) Initial notification/Amendment Initial Notification
---- ------------------------------------------------------- -------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Oncimmune Holdings Plc
---- ------------------------------------------------------- -------------------------------------------------------
b) LEI N/A
---- ------------------------------------------------------- -------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of options over 1p ordinary shares - 2016 Share Option
instrument Plan
Identification code ISIN GB00BYQ94H38
---- ------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Grant of options over ordinary shares
---- ------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- ----------
N/A 92,593
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
d) Aggregated information Price(s) Volume(s)
---------- ----------
N/A 92,593
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 8 November 2016
---- ------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction N/A
---- ------------------------------------------------------- -------------------------------------------------------
1 Details of the person discharging managerial responsibilities/person closely associated
---- ----------------------------------------------------------------------------------------------------------------
a) Name Andrea Murray
---- ------------------------------------------------------- -------------------------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------------------------------------------------
Chief Operational Scientist and PDMR
a) Position/status
---- ------------------------------------------------------- -------------------------------------------------------
b) Initial notification/Amendment Initial Notification
---- ------------------------------------------------------- -------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Oncimmune Holdings Plc
---- ------------------------------------------------------- -------------------------------------------------------
b) LEI N/A
---- ------------------------------------------------------- -------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of options over 1p ordinary shares - 2016 Share Option
instrument Plan
Identification code ISIN GB00BYQ94H38
---- ------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Grant of options over ordinary shares
---- ------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- ----------
N/A 41,667
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
d) Aggregated information Price(s) Volume(s)
---------- ----------
N/A 41,667
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 8 November 2016
---- ------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction N/A
---- ------------------------------------------------------- -------------------------------------------------------
1 Details of the person discharging managerial responsibilities/person closely associated
---- ----------------------------------------------------------------------------------------------------------------
a) Name Maarten Brusse
---- ------------------------------------------------------- -------------------------------------------------------
2 Reason for the notification
---- ----------------------------------------------------------------------------------------------------------------
Chief Commercial Officer and PDMR
a) Position/status
---- ------------------------------------------------------- -------------------------------------------------------
b) Initial notification/Amendment Initial Notification
---- ------------------------------------------------------- -------------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
---- ----------------------------------------------------------------------------------------------------------------
a) Name Oncimmune Holdings Plc
---- ------------------------------------------------------- -------------------------------------------------------
b) LEI N/A
---- ------------------------------------------------------- -------------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
---- ----------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of options over 1p ordinary shares - 2016 Share Option
instrument Plan
Identification code ISIN GB00BYQ94H38
---- ------------------------------------------------------- -------------------------------------------------------
b) Nature of the transaction Grant of options over ordinary shares
---- ------------------------------------------------------- -------------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- ----------
N/A 74,074
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
d) Aggregated information Price(s) Volume(s)
---------- ----------
N/A 74,074
---------- ----------
---- ------------------------------------------------------- -------------------------------------------------------
e) Date of the transaction 8 November 2016
---- ------------------------------------------------------- -------------------------------------------------------
f) Place of the transaction N/A
---- ------------------------------------------------------- -------------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBIBDBSDGBGLI
(END) Dow Jones Newswires
November 08, 2016 13:25 ET (18:25 GMT)
1 Year Oncimmune Chart |
1 Month Oncimmune Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
